Stock VTGN VISTAGEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Vistagen Therapeutics, Inc.

Equities

VTGN

US92840H4002

Market Closed - Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
3.31 USD -0.60% Intraday chart for Vistagen Therapeutics, Inc. -4.89% -35.60%
Jul. 01 Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell 3000E Index CI
Jul. 01 Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell Microcap Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell 3000E Index
CI
Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell Microcap Index
CI
Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell Microcap Growth Index
CI
Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell 3000E Growth Index
CI
Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell Microcap Value Index
CI
Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell 3000E Value Index
CI
Vistagen Awarded Mental Health America's Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
AQ
Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
BU
Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024
Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
BU
Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024
BU
Vistagen to Present at the Jefferies Global Healthcare Conference
BU
Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology Conference
AQ
Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference
BU
Vistagen Therapeutics, Inc. to Present At the 2024 American Society of Clinical Psychopharmacology Conference
CI
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
BU
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
BU
Vistagen Announces Positive Results from Phase 2A Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
CI
Vistagen to Present at the 2024 Anxiety and Depression Association Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VTGN Stock
  4. News Vistagen Therapeutics, Inc.